ENOSF1
Mitochondrial enolase superfamily member 1
Also known as: ENOF1_HUMAN, FUCD, HSRTSBETA, rTS, TYMSAS
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7L5Y1
- Gene
- ENOSF1
- Ensembl
- ENSG00000132199
- Chromosome
- 18
- Canonical length
- 443 aa
- Protein class
- Enzymes, Predicted intracellular proteins
OverviewNCBI Gene
This gene can encode a mitochondrial enzyme that is thought to convert L-fuconate to 2-keto-3-deoxy-L-fuconate. This locus was originally identified as the source of antisense RNAs of the adjacent thymidylate synthase gene. Splice variants at this locus may contain an alternate 3' exon that is complementary to the 3'UTR and terminal intron of the thymidylate synthase (TS) RNA and may downregulate TS expression. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
443 residues, UniProt reviewed canonical sequence.
>Q7L5Y1|ENOSF1
1 MVRGRISRLS VRDVRFPTSL GGHGADAMHT DPDYSAAYVV IETDAEDGIK GCGITFTLGK
61 GTEVVVCAVN ALAHHVLNKD LKDIVGDFRG FYRQLTSDGQ LRWIGPEKGV VHLATAAVLN
121 AVWDLWAKQE GKPVWKLLVD MDPRMLVSCI DFRYITDVLT EEDALEILQK GQIGKKEREK
181 QMLAQGYPAY TTSCAWLGYS DDTLKQLCAQ ALKDGWTRFK VKVGADLQDD MRRCQIIRDM
241 IGPEKTLMMD ANQRWDVPEA VEWMSKLAKF KPLWIEEPTS PDDILGHATI SKALVPLGIG
301 IATGEQCHNR VIFKQLLQAK ALQFLQIDSC RLGSVNENLS VLLMAKKFEI PVCPHAGGVG
361 LCELVQHLII FDYISVSASL ENRVCEYVDH LHEHFKYPVM IQRASYMPPK DPGYSTEMKE
421 ESVKKHQYPD GEVWKKLLPA QENLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ENOSF1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.19
- Highest tissue expression
- 14 nTPM
Expression across tissuesHPA
Tissue
- kidney: 14 nTPM
- choroid plexus: 13 nTPM
- liver: 13 nTPM
- thyroid gland: 10 nTPM
- adrenal gland: 9.8 nTPM
- pituitary gland: 9.2 nTPM
Single-cell type
- proximal tubule cells: 362 nCPM
- somatotrophs: 327 nCPM
- distal convoluted tubule cells: 286 nCPM
- thyrotrophs: 266 nCPM
- rod photoreceptor cells: 255 nCPM
- oligodendrocytes: 253 nCPM
Immune cell
- gdT-cell: 3.5 nTPM
- naive CD8 T-cell: 3.4 nTPM
- naive CD4 T-cell: 3.3 nTPM
- MAIT T-cell: 2.7 nTPM
- memory CD4 T-cell: 2.4 nTPM
- plasmacytoid DC: 2.4 nTPM
Brain region
- choroid plexus: 7.4 nTPM
- white matter: 7.1 nTPM
- basal ganglia: 5 nTPM
- cerebral cortex: 4.4 nTPM
- hypothalamus: 4.4 nTPM
- thalamus: 4.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ENOSF1.
Disease | AllUniProt
Conditions ENOSF1 is implicated in, by any mechanism.
- Dyskeratosis congenita, digenic (DKCD) MIM:620040
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.35
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.27
- DepMap mean gene effect
- 0.17
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- hydro-lyase activity
- isomerase activity
- magnesium ion binding
- L-fuconate dehydratase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Enolase-like, N-terminal
- Enolase-like, C-terminal domain superfamily
- Mandelate racemase, N-terminal domain
- Mandelate racemase, C-terminal domain
- Mandelate racemase/muconate lactonizing enzyme, conserved site
- L-fuconate dehydratase
- L-rhamnonate dehydratase-like
- Mandelate racemase / muconate lactonizing enzyme, N-terminal domain
- Enolase C-terminal domain-like
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ENOSF1 as an antibody target. Whether an autoantibody or antibody against ENOSF1 could matter depends on whether native ENOSF1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ENOSF1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ENOSF1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...